Cash flow Mesa Laboratories, Inc.

Stocks

MLAB

US59064R1095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-08-14 EDT			5-day change	1st Jan Change
106.04 ^USD	-6.33%		+3.30%	+35.08%

08-10	Mesa Laboratories, Inc., Q1 2027 Earnings Call, Aug 10, 2026
08-10	Mesa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

bf03a52a42a25d78.j8u40wg2UCQiqCysEwULuIsXc7JBST8HNGsBOdVFV18.47mO60l9EWt97FrBanMmj-kjENU0OGlybQBHQ7B3ZAjLn8L-PwchF0zyaQ

Published financial data: MESA LABORATORIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	184M	219M	216M	241M	249M
Total Revenues	184M	219M	216M	241M	249M
Cost of Goods Sold, Total	67.78M	85.39M	81.71M	88.88M	90.86M
Gross Profit	117M	134M	134M	152M	158M
Selling General & Admin Expenses, Total	87.38M	110M	111M	115M	119M
R&D Expenses	15.77M	20.49M	19.3M	19.52M	20.31M
Other Operating Expenses, Total	103M	130M	131M	135M	140M
Operating Income	13.41M	3.32M	3.69M	17.57M	18.51M
Interest Expense, Total	-3.88M	-4.77M	-5.7M	-11.86M	-10.69M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-3.88M	-4.77M	-5.7M	-11.86M	-10.69M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	2.76M	1.06M	2.12M	-1.4M	4.2M
EBT, Excl. Unusual Items	12.28M	-389K	114K	4.31M	12.01M
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-8.71M	-	-1.23M	-1.23M	-
Impairment of Goodwill	-	-	-157M	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-118M	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	2.89M	-
EBT, Incl. Unusual Items	3.57M	-389K	-276M	5.96M	12.01M
Income Tax Expense	1.7M	-1.32M	-21.4M	7.94M	5.3M
Earnings From Continuing Operations	1.87M	930K	-254M	-1.97M	6.71M
Net Income to Company	1.87M	930K	-254M	-1.97M	6.71M
Net Income - (IS)	1.87M	930K	-254M	-1.97M	6.71M
Net Income to Common Incl Extra Items	1.87M	930K	-254M	-1.97M	6.71M
Net Income to Common Excl. Extra Items	1.87M	930K	-254M	-1.97M	6.71M
Per Share Items
Net EPS - Basic	0.36	0.17	-47.2	-0.36	1.22
Basic EPS - Continuing Operations	0.36	0.17	-47.2	-0.36	1.22
Basic Weighted Average Shares Outstanding	5.21M	5.32M	5.39M	5.42M	5.51M
Net EPS - Diluted	0.35	0.17	-47.2	-0.36	1.21
Diluted EPS - Continuing Operations	0.35	0.17	-47.2	-0.36	1.21
Diluted Weighted Average Shares Outstanding	5.34M	5.36M	5.39M	5.42M	5.56M
Normalized Basic EPS	1.47	-0.05	0.01	0.5	1.36
Normalized Diluted EPS	1.44	-0.05	0.01	0.5	1.35
Dividend Per Share	0.64	0.64	0.64	0.64	0.64
Payout Ratio	178.46	366.24	-1.36	-175.68	52.49
Supplemental Items
EBITDA	38.48M	37.14M	35.26M	42.1M	41.78M
EBITA	35.21M	32.14M	31.03M	36.71M	36.53M
EBIT	13.41M	3.32M	3.69M	17.57M	18.51M
EBITDAR	40.87M	40.91M	39.24M	48.01M	48.94M
Total Revenues (As Reported)	184M	219M	216M	241M	249M
Effective Tax Rate - (Ratio)	47.65	339.07	7.76	133.12	44.13
Current Domestic Taxes	203K	1.13M	4.68M	5.21M	1.26M
Current Foreign Taxes	1.37M	1.07M	2.33M	2.79M	5.33M
Total Current Taxes	1.58M	2.2M	7.01M	8M	6.58M
Deferred Domestic Taxes	2.04M	-1.64M	-22.24M	76K	1.89M
Deferred Foreign Taxes	-1.92M	-1.88M	-6.17M	-137K	-3.17M
Total Deferred Taxes	128K	-3.52M	-28.41M	-61K	-1.28M
Normalized Net Income	7.68M	-243K	71.25K	2.69M	7.51M
Interest on Long-Term Debt	3.88M	4.77M	5.7M	11.86M	10.69M
Supplemental Operating Expense Items
Selling and Marketing Expenses	28.31M	37.44M	38.62M	41.68M	40.79M
General and Administrative Expenses	59.07M	72.44M	72.87M	73.33M	78.66M
Research And Development Expense From Footnotes	15.77M	20.49M	19.3M	19.52M	20.31M
Net Rental Expense, Total	2.39M	3.77M	3.98M	5.91M	7.16M
Imputed Operating Lease Interest Expense	395K	684K	858K	2.64M	3.38M
Imputed Operating Lease Depreciation	2M	3.08M	3.13M	3.27M	3.78M
Stock-Based Comp., Other (Total)	11.39M	12.54M	11.94M	13.14M	17.87M
Total Stock-Based Compensation	11.39M	12.54M	11.94M	13.14M	17.87M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	49.35M	32.91M	28.21M	27.32M	26.93M
Short Term Investments	-	-	-	1.75M	1.64M
Total Cash And Short Term Investments	49.35M	32.91M	28.21M	29.07M	28.57M
Accounts Receivable, Total	41.22M	42.55M	39.06M	41.97M	44.1M
Total Receivables	41.22M	42.55M	39.06M	41.97M	44.1M
Inventory	24.61M	34.64M	32.68M	25.36M	26.37M
Prepaid Expenses	9.14M	8.87M	9.41M	2.36M	2.78M
Other Current Assets, Total	-	-	-	3.91M	4.44M
Total Current Assets	124M	119M	109M	103M	106M
Gross Property Plant And Equipment	56.55M	56.61M	63.96M	75.14M	78.23M
Accumulated Depreciation	-17.73M	-19.77M	-22.52M	-26.42M	-30.12M
Net Property Plant And Equipment	38.82M	36.84M	41.44M	48.72M	48.11M
Goodwill	291M	286M	180M	182M	187M
Other Intangibles, Total	250M	217M	114M	96.88M	83.35M
Deferred Tax Assets Long-Term	1.32M	1.08M	1.29M	1.37M	1.5M
Other Long-Term Assets, Total	1.63M	1.68M	867K	1.94M	1.66M
Total Assets	707M	662M	447M	433M	428M
Liabilities
Accounts Payable, Total	7.9M	6.13M	6.04M	5.75M	4.93M
Accrued Expenses, Total	21.88M	17.67M	18.19M	27.46M	28.19M
Current Portion of Long-Term Debt	-	-	-	101M	5.62M
Current Portion of Leases	2.77M	2.87M	2.99M	3.52M	3.69M
Current Income Taxes Payable	928K	992K	1.62M	2.16M	4.74M
Unearned Revenue Current, Total	13.83M	14.41M	15.48M	14.71M	14.72M
Other Current Liabilities	751K	1.29M	-	9.32M	-
Total Current Liabilities	48.06M	43.36M	44.31M	164M	61.9M
Long-Term Debt	218M	183M	222M	76.9M	146M
Long-Term Leases	7.44M	5.75M	6.61M	12.38M	13.66M
Unearned Revenue Non Current	-	1.69M	208K	92K	-
Deferred Tax Liability Non Current	39.22M	34.03M	19.78M	20.18M	20.08M
Other Non Current Liabilities	488K	250K	8.79M	-	-
Total Liabilities	314M	268M	301M	274M	242M
Common Stock, Total	313M	332M	344M	359M	375M
Retained Earnings	76.68M	74.2M	-183M	-189M	-186M
Comprehensive Income and Other	3.67M	-12.8M	-14.76M	-9.78M	-3.36M
Total Common Equity	394M	393M	145M	160M	186M
Total Equity	394M	393M	145M	160M	186M
Total Liabilities And Equity	707M	662M	447M	433M	428M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.27M	5.37M	5.41M	5.46M	5.52M
ECS Total Common Shares Outstanding	5.27M	5.37M	5.39M	5.46M	5.52M
Book Value / Share	74.79	73.28	26.95	29.3	33.71
Tangible Book Value	-147M	-110M	-148M	-119M	-83.96M
Tangible Book Value Per Share	-28.01	-20.45	-27.52	-21.78	-15.2
Total Debt	229M	192M	231M	194M	169M
Net Debt	179M	159M	203M	165M	140M
Debt Equivalent Oper. Leases	19.14M	30.14M	31.86M	47.3M	57.27M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	14.17M	20.06M	18.34M	14.78M	14.87M
Inventories - Work In Process, Total	4.42M	617K	1.26M	560K	925K
Inventories - Finished Goods, Total	6.02M	13.96M	13.08M	10.03M	10.58M
Land - (BS)	889K	889K	889K	889K	889K
Buildings, Total	21.54M	22M	23.48M	23.28M	23.37M
Machinery, Total	21.86M	18.89M	23.15M	25.79M	27.08M
Full Time Employees	681	698	736	730	717
Accumulated Allowance for Doubtful Accounts (Supple)	630K	849K	1.32M	1.19M	2.57M
Order Backlog	21.3M	38.1M	25.5M	43.2M	33.6M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	1.87M	930K	-254M	-1.97M	6.71M
Depreciation & Amortization - CF	3.26M	5M	4.23M	5.38M	5.25M
Amortization of Goodwill and Intangible Assets - (CF)	21.81M	28.82M	27.34M	19.14M	18.02M
Depreciation & Amortization, Total	25.07M	33.82M	31.57M	24.53M	23.27M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	275M	-	-
Stock-Based Compensation (CF)	11.39M	12.54M	11.94M	13.14M	17.87M
Other Operating Activities, Total	8.08M	-2.2M	-25.64M	4.21M	-33K
Change In Accounts Receivable	-6.75M	-2.12M	4.94M	-2.92M	-3.21M
Change In Inventories	-1.04M	-10.18M	2.56M	1.15M	-4.43M
Change In Accounts Payable	1.37M	-1.54M	-97K	-388K	-1.2M
Change in Unearned Revenues	2.59M	606K	-408K	-938K	-255K
Change in Other Net Operating Assets	-3.35M	-3.87M	-1.02M	10M	4.1M
Cash from Operations	39.22M	27.98M	44.13M	46.81M	42.83M
Capital Expenditure	-4.43M	-4.54M	-2.57M	-4.25M	-3.25M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-301M	-4.95M	-78.74M	-	-
Sale (Purchase) of Intangible assets	-	-	-	-250K	-
Cash from Investing	-305M	-9.49M	-81.31M	-4.5M	-3.25M
Long-Term Debt Issued, Total	70M	-	71M	73.46M	108M
Total Debt Issued	70M	-	71M	73.46M	108M
Long-Term Debt Repaid, Total	-21M	-36M	-33.5M	-116M	-134M
Total Debt Repaid	-21M	-36M	-33.5M	-116M	-134M
Issuance of Common Stock	7.15M	7M	358K	2.64M	-
Repurchase of Common Stock	-	-919K	-728K	-887K	-1.06M
Common Dividends Paid	-3.34M	-3.41M	-3.45M	-3.47M	-3.52M
Common & Preferred Stock Dividends Paid	-3.34M	-3.41M	-3.45M	-3.47M	-3.52M
Other Financing Activities, Total	-237K	-	-847K	-452K	-10.52M
Cash from Financing	52.58M	-33.33M	32.84M	-44.51M	-41.85M
Foreign Exchange Rate Adjustments	-1.09M	-1.6M	-359K	1.31M	1.88M
Net Change in Cash	-215M	-16.44M	-4.7M	-893K	-393K
Supplemental Items
Cash Interest Paid	2.76M	3.48M	4.65M	11.08M	10.02M
Cash Income Tax Paid (Refund)	3.05M	1.36M	4.59M	5.73M	1.87M
Levered Free Cash Flow	16.62M	25.02M	45.45M	60.43M	31.88M
Unlevered Free Cash Flow	19.05M	28M	49.01M	67.84M	38.57M
Change In Net Working Capital	21.36M	15.89M	-5.76M	-23.7M	10.89M
Net Debt Issued / Repaid	49M	-36M	37.5M	-42.35M	-26.75M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	1.28	0.3	0.42	2.5	2.69
Return on Total Capital	1.43	0.34	0.48	3.01	3.26
Return On Equity %	0.47	0.24	-94.36	-1.29	3.88
Return on Common Equity	0.47	0.24	-94.36	-1.29	3.88
Margin Analysis
Gross Profit Margin %	63.23	61.02	62.2	63.12	63.53
SG&A Margin	47.4	50.16	51.57	47.73	47.95
EBITDA Margin %	20.87	16.95	16.31	17.47	16.77
EBITA Margin %	19.1	14.67	14.35	15.24	14.66
EBIT Margin %	7.27	1.52	1.71	7.29	7.43
Income From Continuing Operations Margin %	1.01	0.42	-117.6	-0.82	2.69
Net Income Margin %	1.01	0.42	-117.6	-0.82	2.69
Net Avail. For Common Margin %	1.01	0.42	-117.6	-0.82	2.69
Normalized Net Income Margin	4.16	-0.11	0.03	1.12	3.01
Levered Free Cash Flow Margin	9.02	11.42	21.02	25.08	12.8
Unlevered Free Cash Flow Margin	10.33	12.78	22.67	28.15	15.48
Asset Turnover
Asset Turnover	0.28	0.32	0.39	0.55	0.58
Fixed Assets Turnover	5.89	5.79	5.52	5.35	5.15
Receivables Turnover (Average Receivables)	5.67	5.23	5.3	5.95	5.79
Inventory Turnover (Average Inventory)	3.79	2.88	2.43	3.06	3.51
Short Term Liquidity
Current Ratio	2.59	2.74	2.47	0.63	1.72
Quick Ratio	1.88	1.74	1.52	0.43	1.17
Operating Cash Flow to Current Liabilities	0.82	0.65	1	0.29	0.69
Days Sales Outstanding (Average Receivables)	64.36	69.79	69.08	61.36	63.05
Days Outstanding Inventory (Average Inventory)	96.35	126.63	150.77	119.18	103.92
Average Days Payable Outstanding	27.8	26.83	27.94	26.37	21.21
Cash Conversion Cycle (Average Days)	132.91	169.58	191.91	154.17	145.76
Long Term Solvency
Total Debt/Equity	58.04	48.77	159.08	121.29	90.65
Total Debt / Total Capital	36.73	32.78	61.4	54.81	47.55
LT Debt/Equity	57.34	48.04	157.03	55.86	85.65
Long-Term Debt / Total Capital	36.28	32.29	60.61	25.24	44.93
Total Liabilities / Total Assets	44.33	40.55	67.46	63.12	56.46
EBIT / Interest Expense	3.45	0.7	0.65	1.48	1.73
EBITDA / Interest Expense	10.52	8.58	6.89	4.05	4.58
(EBITDA - Capex) / Interest Expense	9.38	7.62	6.44	3.69	4.27
Total Debt / EBITDA	5.59	4.69	5.89	4.04	3.45
Net Debt / EBITDA	4.39	3.89	5.17	3.43	2.87
Total Debt / (EBITDA - Capex)	6.27	5.28	6.31	4.43	3.7
Net Debt / (EBITDA - Capex)	4.92	4.37	5.54	3.77	3.07
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	37.63	18.85	-1.32	11.47	3.38
Gross Profit, 1 Yr. Growth %	33.95	14.71	0.59	13.1	4.06
EBITDA, 1 Yr. Growth %	28.18	-0.24	-3.27	19.38	-0.74
EBITA, 1 Yr. Growth %	31.05	-5.38	-3.46	18.32	-0.5
EBIT, 1 Yr. Growth %	8.5	-72.71	11.05	376.48	5.37
Earnings From Cont. Operations, 1 Yr. Growth %	-42.85	-50.29	-27.44K	-99.22	-440.02
Net Income, 1 Yr. Growth %	-42.85	-50.29	-27.44K	-99.22	-440.02
Normalized Net Income, 1 Yr. Growth %	433.22	-103.52	-129.31	3.68K	179.01
Diluted EPS Before Extra, 1 Yr. Growth %	-45.31	-51.43	-27.87K	-99.23	-432.29
Accounts Receivable, 1 Yr. Growth %	73.3	3.22	-8.22	7.46	5.07
Inventory, 1 Yr. Growth %	120.13	40.79	-5.68	-22.37	3.97
Net Property, Plant and Equip., 1 Yr. Growth %	63.12	-5.1	12.47	17.56	-1.24
Total Assets, 1 Yr. Growth %	17.61	-6.44	-32.49	-3.01	-1.29
Tangible Book Value, 1 Yr. Growth %	-210.35	-25.56	35.23	-19.97	-29.33
Common Equity, 1 Yr. Growth %	-3.06	-0.08	-63.05	9.93	16.53
Cash From Operations, 1 Yr. Growth %	5.8	-28.66	57.71	6.06	-8.5
Capital Expenditures, 1 Yr. Growth %	122.49	2.53	-43.51	65.52	-23.51
Levered Free Cash Flow, 1 Yr. Growth %	-53.61	57.97	86.78	27.64	-47.24
Unlevered Free Cash Flow, 1 Yr. Growth %	-53.36	53.29	79.43	33.27	-43.15
Dividend Per Share, 1 Yr. Growth %	0	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	25.15	27.89	8.3	4.88	7.35
Gross Profit, 2 Yr. CAGR %	33.54	23.95	11.03	6.66	8.49
EBITDA, 2 Yr. CAGR %	35.64	11.24	8.83	7.46	8.85
EBITA, 2 Yr. CAGR %	37.74	9.37	8.19	6.88	8.5
EBIT, 2 Yr. CAGR %	30.09	-48.17	-11.45	130.03	124.07
Earnings From Cont. Operations, 2 Yr. CAGR %	2.58	-46.7	1.07K	45.69	-83.75
Net Income, 2 Yr. CAGR %	2.58	-46.7	1.07K	45.69	-83.75
Normalized Net Income, 2 Yr. CAGR %	78.32	-58.9	-82.14	232.71	926.58
Diluted EPS Before Extra, 2 Yr. CAGR %	-7.61	-48.46	1.06K	46.36	-83.99
Accounts Receivable, 2 Yr. CAGR %	39.67	33.75	-2.67	-0.69	6.26
Inventory, 2 Yr. CAGR %	31.5	76.04	15.24	-14.43	-10.16
Net Property, Plant and Equip., 2 Yr. CAGR %	25.76	24.42	3.31	14.99	7.75
Total Assets, 2 Yr. CAGR %	31.49	4.9	-20.52	-19.08	-2.16
Tangible Book Value, 2 Yr. CAGR %	88.76	-9.37	0.33	4.03	-24.79
Common Equity, 2 Yr. CAGR %	33.79	-1.58	-39.24	-36.27	13.18
Cash From Operations, 2 Yr. CAGR %	20.55	-13.12	6.07	29.33	-1.49
Capital Expenditures, 2 Yr. CAGR %	72.01	51.03	-23.9	-3.3	12.52
Levered Free Cash Flow, 2 Yr. CAGR %	105.58	-16.42	101.65	57.59	-17.94
Unlevered Free Cash Flow, 2 Yr. CAGR %	60.74	-17.19	89.8	57.6	-12.96
Dividend Per Share, 2 Yr. CAGR %	0	0	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.36	23.02	17.3	9.34	4.38
Gross Profit, 3 Yr. CAGR %	24.15	26.94	15.62	11.72	5.79
EBITDA, 3 Yr. CAGR %	12.14	21.1	5.51	12.24	4.65
EBITA, 3 Yr. CAGR %	12.18	20.09	4.91	11.47	4.36
EBIT, 3 Yr. CAGR %	-9.11	-25.17	-33.18	55.17	77.32
Earnings From Cont. Operations, 3 Yr. CAGR %	-37	-19.43	326.64	1.8	93.25
Net Income, 3 Yr. CAGR %	-37	-19.43	326.64	1.8	93.25
Normalized Net Income, 3 Yr. CAGR %	-9.73	-53.47	-63.28	6.41	213.75
Diluted EPS Before Extra, 3 Yr. CAGR %	-42.7	-25.43	319.38	1.33	92.36
Accounts Receivable, 3 Yr. CAGR %	48.79	26.28	17.97	0.6	1.2
Inventory, 3 Yr. CAGR %	53.74	34.52	42.98	1.02	-8.69
Net Property, Plant and Equip., 3 Yr. CAGR %	20.43	14.5	20.3	7.86	9.3
Total Assets, 3 Yr. CAGR %	65.25	17.39	-9.43	-15.07	-13.54
Tangible Book Value, 3 Yr. CAGR %	132.63	38.42	3.57	-6.95	-8.55
Common Equity, 3 Yr. CAGR %	52.37	21.38	-29	-25.96	-22.07
Cash From Operations, 3 Yr. CAGR %	8.68	1.21	5.98	6.07	15.24
Capital Expenditures, 3 Yr. CAGR %	52	44.76	8.82	-1.4	-10.57
Levered Free Cash Flow, 3 Yr. CAGR %	-19.11	85.32	8.26	75.52	9.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	-16.31	56.03	6.27	70.85	12.19
Dividend Per Share, 3 Yr. CAGR %	0	0	0	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.5	17.9	15.95	15.41	13.22
Gross Profit, 5 Yr. CAGR %	16.67	19.61	17.16	18.4	12.71
EBITDA, 5 Yr. CAGR %	8.38	7.84	5.26	15.02	6.84
EBITA, 5 Yr. CAGR %	8.48	6.99	4.46	14.62	6.33
EBIT, 5 Yr. CAGR %	-4.63	-26.99	-27.06	17.26	8.42
Earnings From Cont. Operations, 5 Yr. CAGR %	-30.06	-20.68	102.41	2.11	15.44
Net Income, 5 Yr. CAGR %	-30.06	-20.68	102.41	2.11	15.44
Normalized Net Income, 5 Yr. CAGR %	-3.89	-51.24	-63.12	2.2	39.15
Diluted EPS Before Extra, 5 Yr. CAGR %	-34.53	-26.45	90.94	-2.34	13.58
Accounts Receivable, 5 Yr. CAGR %	23.55	24.37	25.56	14.71	13.14
Inventory, 5 Yr. CAGR %	12.14	30.29	36.99	12.26	18.73
Net Property, Plant and Equip., 5 Yr. CAGR %	8.35	9.32	13.27	14.69	15.12
Total Assets, 5 Yr. CAGR %	32.73	32.17	23.3	1.16	-6.59
Tangible Book Value, 5 Yr. CAGR %	64.82	64.8	66.18	23.48	-8.88
Common Equity, 5 Yr. CAGR %	32.12	31.69	5.49	-6.19	-14.44
Cash From Operations, 5 Yr. CAGR %	17.78	1.7	7.63	11.64	2.93
Capital Expenditures, 5 Yr. CAGR %	-17.51	10.18	15.26	23.18	10.29
Levered Free Cash Flow, 5 Yr. CAGR %	26.35	3.71	7.68	72.72	-2.3
Unlevered Free Cash Flow, 5 Yr. CAGR %	29.84	4.93	8.57	55.88	-1.14
Dividend Per Share, 5 Yr. CAGR %	0	0	0	0	0